OCEANSIDE, Calif.--(BUSINESS WIRE)--Scientists at Lifeline Cell Technology, LLC, a wholly owned subsidiary of International Stem Cell Corporation (OTCBB:ISCO), have successfully created six unique human stem cell lines that appear capable of differentiation into any cell type found in the human body using an efficient method that does not require the use of fertilized embryos.